Lv34
392 积分 2025-12-18 加入
Cancer-Related Alopecia Risk and Treatment
5天前
已完结
Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management Strategies
5天前
已完结
Oral Budesonide in Oncology: A Novel Approach to Managing Gastrointestinal Immune-Related Adverse Events
5天前
已完结
Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer
5天前
已完结
Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical Management
5天前
已完结
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
9天前
已完结
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations
13天前
已完结
Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial
13天前
已完结
Skin Reactions and Other Underappreciated Dermatologic Side Effects of Cancer Therapies
23天前
已完结
Endocrinologic Toxicities of Cancer Therapy: Evolving Challenges and Multidisciplinary Approaches
23天前
已完结
皖公网安备34019202002308
